QuickLinks -- Click here to rapidly navigate through this document
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Onconova Therapeutics, Inc. (the "Company") for the year ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, Mark Guerin, Vice President, Financial Planning and Accounting of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:
- (1)
- The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
- (2)
- The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | |
/s/ MARK GUERIN
Mark Guerin
Vice President, Financial Planning and Accounting
and Chief Accounting Officer
(Principal Financial Officer
and Principal Accounting Officer) | | |
Dated: March 28, 2016
QuickLinks
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
